# OnCo record nct06697301 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06697301/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06697301", "NCT06697301" ;
  schema:name "Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma"@en ;
  schema:alternateName "TeLuRide-006"@en ;
  schema:description "A phase 2/3 trial testing EIK1001 in melanoma, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06697301/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06697301> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2025-05-22" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/advanced-melanoma/> ;
  onco:drugs <https://onco.cc/drugs/eik1001/> ;
  onco:companies <https://onco.cc/companies/eikon-therapeutics/> .